Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
DREILING RICHARD W reported acquisition or exercise transactions in this Form 4 filing.
Aramark director Richard W. Dreiling received an automatic grant of 641 fully vested deferred stock units of common stock, based on a reference price of $42.86 per share. These units represent the director’s election to defer all of his cash retainer into stock-based compensation.
The deferred stock units will be settled in shares of common stock on the first day of the seventh month after his departure from the board. Following this grant, Dreiling directly holds 14,502.162 shares of Aramark common stock.
Creed Greg reported acquisition or exercise transactions in this Form 4 filing.
Aramark director Greg Creed received a grant of 787 fully vested deferred stock units of common stock valued at $42.86 per unit. This represents the director’s election to defer all of his cash retainer into stock-based compensation.
The deferred stock units will be settled in shares of common stock on the first day of the seventh month after the date of his departure from the board. Following this grant, Creed holds 67,354.545 Aramark common shares directly and 12,475 shares indirectly through a trust.
The Vanguard Group reports that it beneficially owns 0 shares of Aramark common stock as filed in Amendment No. 10 to Schedule 13G/A. The filing states Vanguard completed an internal realignment on January 12, 2026 and will report certain subsidiaries separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The filing lists Aramark's principal executive office at 2400 Market St, Philadelphia, PA.
Aramark director Kevin Wills reported an automatic stock-based award tied to dividends. On March 4, 2026, he acquired 47.619 shares of common stock equivalents at a stated price of $0.0000 per share, representing dividend equivalent rights on deferred stock units. After this award, his directly held common stock (and equivalents) totaled 21,903.351 shares. These dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards.
Aramark director Stephen I. Sadove acquired additional common stock through dividend equivalents. On March 4, 2026, he received 258.631 shares of common stock at $0.0000 per share as a grant or award. These dividend equivalent rights accrued on deferred stock units he already held and vest on the same schedules as the underlying awards.
After this transaction, Sadove directly held 102,307.745 shares of Aramark common stock. He also had indirect ownership of 15,000 shares held by a trust, reported as a separate holding.
Aramark director Patricia E. Lopez reported an acquisition of 84.690 shares of common stock-equivalent rights on March 4, 2026. These are dividend equivalent rights credited on deferred stock units in connection with Aramark’s quarterly dividend and carry a price of $0.0000 per share.
After this grant/award acquisition, Lopez’s directly held common stock and related rights total 29,077.206 shares. The dividend equivalent rights vest on the same schedules as the underlying deferred stock unit awards, aligning the additional units with her existing equity compensation timeline.
Aramark director Karen Marie King acquired additional common stock-based rights through a compensation-related adjustment. On March 4, 2026, she received 33.727 dividend equivalent rights tied to Aramark common stock at no cash cost, bringing her directly held total to 42,776.855 shares/units. These dividend equivalent rights accrued on her deferred stock units in connection with Aramark’s quarterly dividend and will vest on the same schedules as the underlying awards.
Aramark director Kenneth M. Keverian acquired additional equity-linked rights through a Form 4 transaction. On 2026-03-04, he was granted 84.6900 dividend equivalent rights in connection with Aramark’s quarterly dividend, tied to deferred stock units he already holds.
These dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards. Following this grant, Keverian’s directly owned position in Aramark common stock and related equity units totaled 29077.2060 shares.
Aramark director Bridgette P. Heller acquired additional share-based units through a non-cash award. On the reported date, she received 104.1 shares of Aramark common stock as a grant tied to dividend equivalent rights on deferred stock units. These dividend equivalent rights accrue in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards. Following this award, her directly held common stock stake reported in this filing increased to 35,741.188 shares.
Aramark director Richard W. Dreiling received additional equity-based compensation through dividend equivalents. On the transaction date, he acquired 39.978 dividend equivalent rights at no cost in connection with Aramark’s quarterly dividend, tied to deferred stock units he already holds. Following this award, his directly owned common stock and related units total 13,861.162 shares.